High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer

被引:38
作者
Kristiansen, M
Knudsen, GPS
Maguire, P
Margolin, S
Pedersen, J
Lindblom, A
Orstavik, KH [1 ]
机构
[1] Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Karolinska Univ Hosp Sodersjukhuset, Dept Oncol, Stockholm, Sweden
[4] Univ Oslo, Rikshosp, Fac Div, N-0027 Oslo, Norway
关键词
D O I
10.1136/jmg.2005.032433
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A higher frequency of skewed X chromosome inactivation has been reported in a consecutive series of young patients with breast cancer compared with controls of a similar age. Objective: To investigate the X inactivation pattern in patients with familial non-BRCA1/BRCA2 breast cancer (n = 272), BRCA1/BRCA2 germline mutations (n = 35), and sporadic breast cancer (n = 292). Methods: X inactivation pattern was determined by polymerase chain reaction analysis of the highly polymorphic CAG repeat in the androgen receptor (AR) gene. The X inactivation pattern was classified as skewed when 90% or more of the cells preferentially expressed one X chromosome. Results: Young patients with familial breast cancer had a significantly higher frequency of skewed X inactivation (11.2%) than young controls (2.7%) (p = 0.001). There was also a strong tendency for middle aged patients with sporadic breast cancer to be more skewed than middle aged controls (13.6% v 4.4%) (p = 0.02). No association between skewed X inactivation and breast cancer was found for the BRCA1/BRCA2 patients. Conclusions: Skewed X inactivation may be a risk factor for the development of breast cancer in both sporadic and familial breast cancer and may indicate an effect of X linked genes.
引用
收藏
页码:877 / 880
页数:4
相关论文
共 23 条
[1]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[2]   Variability of X chromosome inactivation:: effect on levels of TIMP1 RNA and role of DNA methylation [J].
Anderson, CL ;
Brown, CJ .
HUMAN GENETICS, 2002, 110 (03) :271-278
[3]   BRCA1 screening in patients with a family history of breast or ovarian cancer [J].
Arver, B ;
Claro, A ;
Langerod, A ;
Borresen-Dale, AL ;
Lindblom, A .
GENETIC TESTING, 1999, 3 (02) :223-226
[4]   First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm [J].
Arver, B ;
Borg, Å ;
Lindblom, A .
GENETIC TESTING, 2001, 5 (01) :1-8
[5]  
Belmont JW, 1996, AM J HUM GENET, V58, P1101
[6]   The causes and consequences of random and non-random X chromosome inactivation in humans [J].
Brown, CJ ;
Robinson, WP .
CLINICAL GENETICS, 2000, 58 (05) :353-363
[7]   Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer [J].
Buller, RE ;
Sood, AK ;
Lallas, T ;
Buekers, T ;
Skilling, JS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04) :339-346
[8]  
Busque L, 1996, BLOOD, V88, P59
[9]   BRCA2 germline mutations in Swedish breast cancer families [J].
Chen, JD ;
Hedman, MZ ;
Arver, BW ;
Sigurdsson, S ;
Eyfjörd, JE ;
Lindblom, A .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (02) :134-139
[10]   X-linked genetic factors regulate hematopoietic stem-cell kinetics in females [J].
Christensen, K ;
Kristiansen, M ;
Hagen-Larsen, H ;
Skytthe, A ;
Bathum, L ;
Jeune, B ;
Andersen-Ranberg, K ;
Vaupel, JW ;
Orstavik, KH .
BLOOD, 2000, 95 (07) :2449-2451